This site is intended for healthcare professionals
News

High efficacy and no serious safety concerns through up to six months following second dose in updated topline analysis of landmark COVID-19 Vaccine Study. Pfizer + BioNTech SE

Read time: 2 mins
Last updated:2nd Apr 2021
Published:3rd Apr 2021
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest